Table 3.

Favorable microbiologic response assessments in microbiologically evaluable patients with APN or other cUTI, by stratum and time of assessment

APN, acute pyelonephritis; cUTI, complicated urinary tract infection; N, number of evaluable patients in each treatment group; CI, confidence interval; DCIV, discontinuation of intravenous (i.v.) therapy includes patients who completed a regimen of i.v. therapy only and patients who discontinued i.v. and then switched to oral therapy; EFU, early follow-up visit, 5-9 days post-therapy.